Cytokines and plasma factors in sickle cell disease

Julia Elizabeth Brittain, Leslie V. Parise

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Plasma cytokines and related factors represent a burgeoning area of inquiry related to the pathogenesis in sickle cell disease. Cytokines derived from platelets, white blood cells and endothelial cells have all been implicated in the development of several sequelae of this disease. In this review, we seek to provide an overview of the noted and potentially novel roles for several key plasma factors in sickle cell disease. We also consider the putative role for those cytokines implicated by genetic analysis in sickle cell disease, but where the pathogenic, or ameliorative, role has yet to be determined. RECENT FINDINGS: New roles for the platelet as a key mediator in the release of cytokines in sickle cell disease have recently been demonstrated. Angiogenic and inflammatory factors are also being explored in this illness. Members of the vascular endothelial growth factor and transforming growth factor-β superfamilies have been suggested to contribute to several key events in pathogenesis of sickle cell disease, but with the promise of nitrous oxide therapy in this disorder, these cytokines merit a fresh perspective in the context of sickle cell disease. SUMMARY: Increased understanding of the origin and pathology of cytokine levels in sickle cell disease may provide novel therapeutic approaches in the management of the disease.

Original languageEnglish (US)
Pages (from-to)438-443
Number of pages6
JournalCurrent Opinion in Hematology
Volume14
Issue number5
DOIs
StatePublished - Sep 1 2007

Fingerprint

Sickle Cell Anemia
Cytokines
Blood Platelets
Angiogenesis Inducing Agents
Nitrous Oxide
Transforming Growth Factors
Disease Management
Vascular Endothelial Growth Factor A
Leukocytes
Endothelial Cells
Pathology
Therapeutics

Keywords

  • Inflammation
  • Leukocyte
  • Nitric oxide
  • Platelet
  • Pregnancy
  • Sickle cell disease

ASJC Scopus subject areas

  • Hematology

Cite this

Cytokines and plasma factors in sickle cell disease. / Brittain, Julia Elizabeth; Parise, Leslie V.

In: Current Opinion in Hematology, Vol. 14, No. 5, 01.09.2007, p. 438-443.

Research output: Contribution to journalReview article

Brittain, Julia Elizabeth ; Parise, Leslie V. / Cytokines and plasma factors in sickle cell disease. In: Current Opinion in Hematology. 2007 ; Vol. 14, No. 5. pp. 438-443.
@article{66b289ac1e9d4d48bd050a4fa1690a8e,
title = "Cytokines and plasma factors in sickle cell disease",
abstract = "PURPOSE OF REVIEW: Plasma cytokines and related factors represent a burgeoning area of inquiry related to the pathogenesis in sickle cell disease. Cytokines derived from platelets, white blood cells and endothelial cells have all been implicated in the development of several sequelae of this disease. In this review, we seek to provide an overview of the noted and potentially novel roles for several key plasma factors in sickle cell disease. We also consider the putative role for those cytokines implicated by genetic analysis in sickle cell disease, but where the pathogenic, or ameliorative, role has yet to be determined. RECENT FINDINGS: New roles for the platelet as a key mediator in the release of cytokines in sickle cell disease have recently been demonstrated. Angiogenic and inflammatory factors are also being explored in this illness. Members of the vascular endothelial growth factor and transforming growth factor-β superfamilies have been suggested to contribute to several key events in pathogenesis of sickle cell disease, but with the promise of nitrous oxide therapy in this disorder, these cytokines merit a fresh perspective in the context of sickle cell disease. SUMMARY: Increased understanding of the origin and pathology of cytokine levels in sickle cell disease may provide novel therapeutic approaches in the management of the disease.",
keywords = "Inflammation, Leukocyte, Nitric oxide, Platelet, Pregnancy, Sickle cell disease",
author = "Brittain, {Julia Elizabeth} and Parise, {Leslie V.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1097/MOH.0b013e3282a4a673",
language = "English (US)",
volume = "14",
pages = "438--443",
journal = "Current Opinion in Hematology",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Cytokines and plasma factors in sickle cell disease

AU - Brittain, Julia Elizabeth

AU - Parise, Leslie V.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - PURPOSE OF REVIEW: Plasma cytokines and related factors represent a burgeoning area of inquiry related to the pathogenesis in sickle cell disease. Cytokines derived from platelets, white blood cells and endothelial cells have all been implicated in the development of several sequelae of this disease. In this review, we seek to provide an overview of the noted and potentially novel roles for several key plasma factors in sickle cell disease. We also consider the putative role for those cytokines implicated by genetic analysis in sickle cell disease, but where the pathogenic, or ameliorative, role has yet to be determined. RECENT FINDINGS: New roles for the platelet as a key mediator in the release of cytokines in sickle cell disease have recently been demonstrated. Angiogenic and inflammatory factors are also being explored in this illness. Members of the vascular endothelial growth factor and transforming growth factor-β superfamilies have been suggested to contribute to several key events in pathogenesis of sickle cell disease, but with the promise of nitrous oxide therapy in this disorder, these cytokines merit a fresh perspective in the context of sickle cell disease. SUMMARY: Increased understanding of the origin and pathology of cytokine levels in sickle cell disease may provide novel therapeutic approaches in the management of the disease.

AB - PURPOSE OF REVIEW: Plasma cytokines and related factors represent a burgeoning area of inquiry related to the pathogenesis in sickle cell disease. Cytokines derived from platelets, white blood cells and endothelial cells have all been implicated in the development of several sequelae of this disease. In this review, we seek to provide an overview of the noted and potentially novel roles for several key plasma factors in sickle cell disease. We also consider the putative role for those cytokines implicated by genetic analysis in sickle cell disease, but where the pathogenic, or ameliorative, role has yet to be determined. RECENT FINDINGS: New roles for the platelet as a key mediator in the release of cytokines in sickle cell disease have recently been demonstrated. Angiogenic and inflammatory factors are also being explored in this illness. Members of the vascular endothelial growth factor and transforming growth factor-β superfamilies have been suggested to contribute to several key events in pathogenesis of sickle cell disease, but with the promise of nitrous oxide therapy in this disorder, these cytokines merit a fresh perspective in the context of sickle cell disease. SUMMARY: Increased understanding of the origin and pathology of cytokine levels in sickle cell disease may provide novel therapeutic approaches in the management of the disease.

KW - Inflammation

KW - Leukocyte

KW - Nitric oxide

KW - Platelet

KW - Pregnancy

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=34648826775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648826775&partnerID=8YFLogxK

U2 - 10.1097/MOH.0b013e3282a4a673

DO - 10.1097/MOH.0b013e3282a4a673

M3 - Review article

C2 - 17934349

AN - SCOPUS:34648826775

VL - 14

SP - 438

EP - 443

JO - Current Opinion in Hematology

JF - Current Opinion in Hematology

SN - 1065-6251

IS - 5

ER -